ProfileGDS4718 / 224860_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 49% 80% 54% 70% 62% 61% 62% 52% 60% 61% 55% 58% 67% 52% 62% 70% 53% 66% 45% 57% 64% 58% 65% 64% 63% 60% 66% 56% 61% 64% 69% 42% 60% 63% 67% 68% 59% 61% 84% 56% 61% 64% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.1204760
GSM549102patient 115, normal, homogenized [OPG study]5.4647949
GSM549104patient 119, normal, homogenized [OPG study]7.9615980
GSM549108patient 138, normal, homogenized [OPG study]5.8071854
GSM549119patient 077, normal, homogenized [OPG study]6.844970
GSM549133patient 032, cancer, homogenized [OPG study]6.2400862
GSM549139patient 042, cancer, homogenized [OPG study]6.1576461
GSM549099patient 107, normal, homogenized [OPG study]6.2546262
GSM549109patient 139, normal, homogenized [OPG study]5.632552
GSM549110patient 046, normal, homogenized [OPG study]6.0917260
GSM549114patient 063, normal, homogenized [OPG study]6.1268261
GSM549122patient 082, normal, homogenized [OPG study]5.820155
GSM549134patient 033, cancer, homogenized [OPG study]5.9829258
GSM549136patient 036, cancer, homogenized [OPG study]6.6107467
GSM549140patient 044, cancer, homogenized [OPG study]5.5732952
GSM549111patient 047, normal, homogenized [OPG study]6.2368262
GSM549113patient 057, normal, homogenized [OPG study]6.9235270
GSM549132patient 031, cancer, homogenized [OPG study]5.6776953
GSM549137patient 038, cancer, homogenized [OPG study]6.556966
GSM549142patient 047, cancer, homogenized [OPG study]5.3884845
GSM549100patient 110, normal, homogenized [OPG study]5.9119757
GSM549107patient 135, normal, homogenized [OPG study]6.3821664
GSM549115patient 068, normal, homogenized [OPG study]5.9338158
GSM549116patient 072, normal, homogenized [OPG study]6.4843765
GSM549120patient 078, normal, homogenized [OPG study]6.3906364
GSM549131patient 030, cancer, homogenized [OPG study]6.3297863
GSM549118patient 074, normal, homogenized [OPG study]6.1077560
GSM549129patient 027, cancer, homogenized [OPG study]6.6388266
GSM549123patient 088, normal, homogenized [OPG study]5.8969856
GSM549124patient 006, cancer, homogenized [OPG study]6.1703861
GSM549126patient 015, cancer, homogenized [OPG study]6.401564
GSM549128patient 025, cancer, homogenized [OPG study]6.8746269
GSM549103patient 117, normal, homogenized [OPG study]5.1440942
GSM549117patient 073, normal, homogenized [OPG study]6.0889160
GSM549138patient 041, cancer, homogenized [OPG study]6.3790763
GSM549141patient 045, cancer, homogenized [OPG study]6.7147467
GSM549130patient 028, cancer, homogenized [OPG study]6.7076268
GSM549101patient 111, normal, homogenized [OPG study]6.1133359
GSM549105patient 128, normal, homogenized [OPG study]6.2313661
GSM549106patient 134, normal, homogenized [OPG study]8.5174884
GSM549112patient 048, normal, homogenized [OPG study]5.838856
GSM549125patient 011, cancer, homogenized [OPG study]6.2176561
GSM549127patient 024, cancer, homogenized [OPG study]6.5017164
GSM549135patient 035, cancer, homogenized [OPG study]6.3593663